Published in Drug Alcohol Depend on November 01, 1998
Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci (2007) 1.47
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. Am J Drug Alcohol Abuse (2012) 0.95
Factors associated with relapse into drug use among male and female attendees of a three-month drug detoxification-rehabilitation programme in Dhaka, Bangladesh: a prospective cohort study. Harm Reduct J (2013) 0.92
Short-term UROD treatment on cerebral function in codeine-containing cough syrups dependent male individuals. Eur Radiol (2015) 0.76
Ultrarapid opioid detoxification: current status in iran and controversies. Int J High Risk Behav Addict (2013) 0.75
Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: results of a multinational, randomized, modified double-blind study. Clin Pediatr (Phila) (2001) 1.81
Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur Arch Psychiatry Clin Neurosci (1999) 1.45
A theoretical reappraisal of mixed states: dysphoria as a third dimension. Bipolar Disord (2000) 1.45
Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J Clin Psychiatry (2000) 1.09
Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment. Drug Alcohol Depend (2000) 1.09
Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland. Eur Arch Psychiatry Clin Neurosci (1997) 1.08
Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J (2003) 1.02
Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Mol Psychiatry (2006) 1.01
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. J Immunol Methods (2001) 0.99
"INTERMED": a method to assess health service needs. II. Results on its validity and clinical use. Gen Hosp Psychiatry (1999) 0.99
INTERMED--an assessment and classification system for case complexity. Results in patients with low back pain. Spine (Phila Pa 1976) (1999) 0.98
Prevalence of pathological gambling in Switzerland after the opening of casinos and the introduction of new preventive legislation. Acta Psychiatr Scand (2008) 0.95
Cytochrome P450 2D6 genotype and methadone steady-state concentrations. J Clin Psychopharmacol (2001) 0.94
Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: a critical appraisal of the last 10 years. Neurophysiol Clin (2006) 0.93
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol (1997) 0.93
Fluvoxamine-tricyclic antidepressant interaction. An accidental finding. Eur J Clin Pharmacol (1991) 0.93
High interindividual variability of methadone enantiomer blood levels to dose ratios. Arch Gen Psychiatry (1998) 0.92
Inter-informant agreement and prevalence estimates for substance use disorders: direct interview versus family history method. Drug Alcohol Depend (2007) 0.91
Prognostic implications of expression of the cellular genes myc, fos, Ha-ras and Ki-ras in colon carcinoma. Int J Cancer (1987) 0.90
DNA synthesis in circulating erythroblasts of anemic duck. Isolation and properties of nuclear and cytoplasmic-nonmitochondrial DNA. Eur J Biochem (1975) 0.90
Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry (2000) 0.90
Prevalence estimates of pathological gambling in Switzerland. Acta Psychiatr Scand (2000) 0.89
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation. Psychopharmacology (Berl) (1996) 0.87
Study on the structure and properties of wool keratin regenerated from formic acid. Int J Biol Macromol (2007) 0.87
Spectrographic differences between tracheal-esophageal and esophageal voice. Folia Phoniatr Logop (1996) 0.86
Clinical relevance of adjustment disorder in DSM-III-4 and DSM-IV. Compr Psychiatry (1996) 0.85
[Prediction of suicide risk]. Encephale (1991) 0.84
Dark-rearing decreases NR2A N-methyl-D-aspartate receptor subunit in all visual cortical layers. Neuroscience (2003) 0.84
β-Arrestin2 influences the response to methadone in opioid-dependent patients. Pharmacogenomics J (2010) 0.84
Insulin resistance in the aged: the role of the peripheral insulin receptors. Metabolism (1981) 0.83
The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients. Pharmacopsychiatry (2002) 0.82
No influence of ABCB1 haplotypes on methadone dosage requirement. Clin Pharmacol Ther (2008) 0.82
Tricyclic antidepressant plasma level monitoring: intraindividual variability in everyday practice. Eur J Clin Pharmacol (1990) 0.82
Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results. Drug Alcohol Depend (2003) 0.81
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients. Pharmacol Res (1995) 0.81
Dichorionic pregnancy: delayed interval delivery with endoloop ligation. Twin Res Hum Genet (2012) 0.81
Expressed emotion and first-admission schizophrenia. Nine-month follow-up in a French cultural environment. Br J Psychiatry (1990) 0.81
The French version of the Defense Style Questionnaire. Psychother Psychosom (1998) 0.80
Is executive function associated with symptom severity in schizophrenia? Eur Arch Psychiatry Clin Neurosci (2003) 0.80
Debrisoquine oxidative phenotyping and psychiatric drug treatment. Eur J Clin Pharmacol (1989) 0.79
A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study. Swiss Med Wkly (2006) 0.79
[Translation and validation of a French version of the Young Mania Rating Scale (YMRS)]. Encephale (2004) 0.79
[Modifications of complex acoustic stimuli registered by the CPM]. Acta Otolaryngol (1967) 0.79
Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children. Infection (1998) 0.78
Mania resulting from continuous positive airways pressure in a depressed man with sleep apnea syndrome. Neuropsychobiology (2001) 0.78
Alcohol Use and Frailty in Community-Dwelling Older Persons Aged 65 to 70 Years. J Frailty Aging (2014) 0.78
Mania induced by citalopram. Arch Gen Psychiatry (1994) 0.78
Risperidone and reversible neutropenia: a negative rechallenge. Eur Neuropsychopharmacol (1996) 0.78
Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients. Ther Drug Monit (1988) 0.77
Risk factors in newborns with severe acidosis at birth. Panminerva Med (2007) 0.77
Screening for bipolar disorder among outpatients with substance use disorders. Eur Psychiatry (2011) 0.77
[Subjective perception of the effect of neuroleptics by outpatient schizophrenic patients: a cross-sectional study]. Encephale (1999) 0.76
Debrisoquine and dextromethorphan phenotyping and antidepressant treatment. Therapie (1991) 0.76
A double-blind double-dummy study of citalopram comparing infusion versus oral administration. J Affect Disord (1998) 0.76
Nonlinear kinetics of nortriptyline in every day practice. Eur J Clin Pharmacol (1990) 0.76
Tricyclic antidepressant plasma levels after fluoxetine addition. Neuropsychobiology (1992) 0.75
[The mode of induction of amineptine dependence. 8 cases]. Therapie (1990) 0.75
[A survey of the practice of psychotherapy by physicians from Vaud (performed in May-June 1987)]. Rev Med Suisse Romande (1989) 0.75
Amitriptyline: linear or nonlinear kinetics in every day practice? Eur J Clin Pharmacol (1989) 0.75
Psychotherapeutic treatments evaluated with two instruments: clinical questionnaire and semantic differential. Psychother Psychosom (1991) 0.75
[Plasma desipramine levels and clinical response in patients with major depression. Results in agreement with a curvilinear relationship]. Therapie (1989) 0.75
[The ultrasensitive thyrotropin assay and thyroliberin test in patients with major depression]. Presse Med (1989) 0.75
[Anxiety and depression]. Soins Psychiatr (1989) 0.75
Pharmacokinetics of fluoxetine and fluvoxamine in depressed patients: personal results. Clin Neuropharmacol (1992) 0.75
[Psychiatry]. Rev Med Suisse (2005) 0.75
[Compliance, subdosage and overdosage of antidepressive agents in the first prescription in a hospital milieu]. Therapie (1990) 0.75
Antidepressant treatment before hospitalization for major depression: often prescribed, often undertitrated. Pharmacol Res (1997) 0.75
[Undesirable effects of drugs. Epidemiologic study at a psychiatric service of a university hospital]. Therapie (1995) 0.75
Bradycardia during citalopram treatment: a case report. Pharmacol Res (1999) 0.75
[Panic attacks and agoraphobia]. Soins Psychiatr (1989) 0.75
[Psychiatry]. Rev Med Suisse (2007) 0.75
Nefazodone may inhibit the metabolism of carbamazepine: three case reports. Eur Psychiatry (2001) 0.75
[Obsessive-compulsive disorders]. Soins Psychiatr (1989) 0.75
[Addiction and exclusion]. Rev Med Suisse Romande (1995) 0.75
Hypomania-like syndrome induced by olanzapine. Int Clin Psychopharmacol (1999) 0.75
Minor and clinically non-significant interaction between toloxatone and amitriptyline. Eur J Clin Pharmacol (1993) 0.75
[Prescription of an antidepressive agent]. Soins Psychiatr (1988) 0.75
Application of Osgood's Semantic Differential to the study of psychotherapeutic treatments. Psychother Psychosom (1988) 0.75
Rhabdomyolysis after moderate alcohol abuse and physical training during amesergide treatment. Therapie (1995) 0.75
Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic states. Nord J Psychiatry (2006) 0.75
Observations of the interaction between tricyclic antidepressants and fluvoxamine in poor metabolizers of dextromethorphan and mephenytoin. Therapie (1997) 0.75
[The place of psychiatry in the management network of drug addicts: apropos of public psychiatry in Lausanne]. Rev Med Suisse Romande (1993) 0.75
[Consumption of benzodiazepines in a university hospital center]. Encephale (1993) 0.75
Can home-monitoring of sleep predict depressive episodes in bipolar patients? Conf Proc IEEE Eng Med Biol Soc (2015) 0.75
[The epidemiology of anxiety]. Soins Psychiatr (1989) 0.75
Fluoxetine and norfluoxetine plasma levels after treatment discontinuation in man. Therapie (1995) 0.75
[Comparative study of ambulatory clients in private and public psychiatry]. Rev Med Suisse Romande (1992) 0.75
[Interaction between fluvoxamine and tricyclic antidepressants. Some precise details]. Therapie (1993) 0.75
[Comparative study of two techniques for the determination of amitriptyline and nortriptyline: EMIT and gas chromatography]. Therapie (1992) 0.75
Panic disorder in benin, west Africa. Am J Psychiatry (1992) 0.75
[Thyroid function in depressed patients]. Encephale (1996) 0.75
Long-term treatment of depression: is there a use for depot antidepressants? Int Clin Psychopharmacol (1997) 0.75
[Current topics in pharmacokinetics and pharmacogenetics of antidepressant drugs]. Rev Med Suisse (2009) 0.75
Fluoxetine-related indifference and akathisia. A case report. Therapie (1993) 0.75
Lithium dose prediction based on 24 hours single dose levels: a prospective evaluation. Pharmacol Res (2003) 0.75
[Role of the family physician in the prevention of drug addiction]. Rev Med Suisse Romande (1993) 0.75
[Clinical evaluation of the effects of antidepressive agents]. Soins Psychiatr (1988) 0.75
[Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration]. Encephale (1996) 0.75
[The major depression with psychotic symptoms]. Rev Med Suisse (2008) 0.75